225 related articles for article (PubMed ID: 33194656)
1. Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
Xu T; Zhang Y; Zhang J; Qi C; Liu D; Wang Z; Li Y; Ji C; Li J; Lin X; Hou T; Liu H; Zhang L; Han-Zhang H; Shen L; Wang X
Front Oncol; 2020; 10():568911. PubMed ID: 33194656
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
Cercek A; Chatila WK; Yaeger R; Walch H; Fernandes GDS; Krishnan A; Palmaira L; Maio A; Kemel Y; Srinivasan P; Bandlamudi C; Salo-Mullen E; Tejada PR; Belanfanti K; Galle J; Joseph V; Segal N; Varghese A; Reidy-Lagunes D; Shia J; Vakiani E; Mondaca S; Mendelsohn R; Lumish MA; Steinruecke F; Kemeny N; Connell L; Ganesh K; Markowitz A; Nash G; Guillem J; Smith JJ; Paty PB; Zhang L; Mandelker D; Birsoy O; Robson M; Offit K; Taylor B; Berger M; Solit D; Weiser M; Saltz LB; Aguilar JG; Schultz N; Diaz LA; Stadler ZK
J Natl Cancer Inst; 2021 Nov; 113(12):1683-1692. PubMed ID: 34405229
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
[TBL] [Abstract][Full Text] [Related]
4. Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer.
Huang YH; Lin PC; Su WC; Chan RH; Chen PC; Lin BW; Shen MR; Chen SH; Yeh YM
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943546
[TBL] [Abstract][Full Text] [Related]
5. 'Druggable' alterations detected by Ion Torrent in metastatic colorectal cancer patients.
Fang W; Radovich M; Zheng Y; Fu CY; Zhao P; Mao C; Zheng Y; Zheng S
Oncol Lett; 2014 Jun; 7(6):1761-1766. PubMed ID: 24932229
[TBL] [Abstract][Full Text] [Related]
6. Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer.
Peng H; Ying J; Zang J; Lu H; Zhao X; Yang P; Wang X; Li J; Gong Z; Zhang D; Wang Z
Cancer Res Treat; 2023 Oct; 55(4):1270-1280. PubMed ID: 37114476
[TBL] [Abstract][Full Text] [Related]
7. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
[TBL] [Abstract][Full Text] [Related]
9. Mutational Status of
Lahoz S; Rodríguez A; Fernández L; Gorría T; Moreno R; Esposito F; Oliveres H; Albiol S; Saurí T; Pesantez D; Riu G; Cuatrecasas M; Jares P; Pedrosa L; Pineda E; Postigo A; Castells A; Prat A; Maurel J; Camps J
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497403
[TBL] [Abstract][Full Text] [Related]
10. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
Kim JE; Choi J; Sung CO; Hong YS; Kim SY; Lee H; Kim TW; Kim JI
Exp Mol Med; 2021 Mar; 53(3):446-456. PubMed ID: 33753878
[TBL] [Abstract][Full Text] [Related]
12. Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project.
Lee Y; Lee S; Sung JS; Chung HJ; Lim AR; Kim JW; Choi YJ; Park KH; Kim YH
Cancer Res Treat; 2021 Jan; 53(1):123-130. PubMed ID: 32810930
[TBL] [Abstract][Full Text] [Related]
13. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
[TBL] [Abstract][Full Text] [Related]
14. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.
Grothey A; Fakih M; Tabernero J
Ann Oncol; 2021 Aug; 32(8):959-967. PubMed ID: 33836264
[TBL] [Abstract][Full Text] [Related]
15. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
[TBL] [Abstract][Full Text] [Related]
17. Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer.
Gupta R; Othman T; Chen C; Sandhu J; Ouyang C; Fakih M
Oncologist; 2020 Mar; 25(3):235-243. PubMed ID: 32162812
[TBL] [Abstract][Full Text] [Related]
18. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
19. The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer.
Frostberg E; Petersen AH; Bojesen A; Rahr HB; Lindebjerg J; Rønlund K
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680242
[TBL] [Abstract][Full Text] [Related]
20. Impact of Metastasectomy in the Multimodality Approach for
Johnson B; Jin Z; Truty MJ; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Grothey A
Oncologist; 2018 Jan; 23(1):128-134. PubMed ID: 28904173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
